HDAC7 is a potential therapeutic target in acute erythroid leukemia

2024-9-14

Eltrombopag in chronic myelomonocytic leukemia with severe thrombocytopenia. A Groupe Francophone des Myélodysplasies (GFM) study

2024-9-12

USP4 regulates ribosome biogenesis and protein synthesis for hematopoietic stem cell regeneration and leukemia progression

2024-9-12

Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children’s Oncology Group study

2024-9-11

The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia

2024-9-11

CXCR4 as a therapeutic target in acute myeloid leukemia

2024-9-11

Diverse mechanisms of leukemogenesis associated with PAX5 germline mutation

2024-9-10

Are measurable residual disease results after consolidation therapy useful in children with acute lymphoblastic leukemia?

2024-9-10

Early-life tobacco exposure is causally implicated in aberrant RAG-mediated recombination in childhood acute lymphoblastic leukemia

2024-9-9

Cohesin mutations in acute myeloid leukemia

2024-9-9

Plasma cell disorders supress mucosal anti-bacterial immunity: another dimension of immunoparesis in plasma cell neoplasms

2024-9-7

JAK2V617F impairs lymphoid differentiation in myeloproliferative neoplasms

2024-9-7

Phase 3 study of gilteritinib versus salvage chemotherapy in predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia

2024-9-5

Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia

2024-9-4

Genome-wide CRISPR/Cas9 library screening identified OGDH as a regulator of disease progress and resistance to decitabine in myelodysplastic neoplasm by reprogramming glutamine metabolism

2024-9-3

Mosaic chromosomal alterations in hematopoietic cells and clinical outcomes in patients with multiple myeloma

2024-9-2

Star wars against leukemia: attacking the clones

2024-9-2

Correction: Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials

2024-9-2

Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis

2024-8-30

IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma

2024-8-30

The clinical impact of acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia: an underrecognized source of major bleeding events

2024-8-28

Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study

2024-8-27

Genetic hallmarks and clinical implications of chromothripsis in childhood T-cell acute lymphoblastic leukemia

2024-8-27

A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia

2024-8-26

Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation

2024-8-26

Downregulation of UBA1 expression in myelodysplastic neoplasm

2024-8-23

Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms

2024-8-23

Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community

2024-8-23

STING is crucial for the survival of RUNX1::RUNX1T1 leukemia cells

2024-8-23

Evolution of T-cell fitness through AML progression: enhanced bispecific T-cell engager-mediated function of bone marrow T cells at remission compared to initial diagnosis and relapse

2024-8-22

Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML)

2024-8-21

Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties

2024-8-21

Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial

2024-8-20

Prevalence of metabolic comorbidities and viral co-infections in monoclonal gammopathy: a retrospective analysis

2024-8-20

Atrial fibrillation burden and clinical outcomes following BTK inhibitor initiation

2024-8-17

Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials—a LYSA and GLA/ DSHNHL collaboration

2024-8-16

Autophagy in cancer resistance: New combinatorial strategy for cancer therapy

2024-8-15

The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands

2024-8-14

Loss of Dnajc21 leads to cytopenia and altered nucleotide metabolism in zebrafish

2024-8-13

GNAS knockout potentiates HDAC3 inhibition through viral mimicry-related interferon responses in lymphoma

2024-8-8

Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study

2024-8-5

BCR::ABL1 Proteolysis-targeting chimeras (PROTACs): The new frontier in the treatment of Ph+ leukemias?

2024-8-4

Rational combinatorial targeting by adapter CAR-T-cells (AdCAR-T) prevents antigen escape in acute myeloid leukemia

2024-8-3

Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma

2024-8-2

Absence of ABL1 exon 2-encoded SH3 residues in BCR::ABL1 destabilizes the autoinhibited kinase conformation and confers resistance to asciminib

2024-7-31

REXO5 promotes genomic integrity through regulating R-loop using its exonuclease activity

2024-7-30

Tumor evolution analysis uncovered immune-escape related mutations in relapse of diffuse large B-cell lymphoma

2024-7-30

Correction: Targeting CERS6-AS1/FGFR1 axis as synthetic vulnerability to constrain stromal cells supported proliferation in Mantle cell lymphoma

2024-7-29

The m6A methyltransferase METTL14 promotes cell proliferation via SETBP1-mediated activation of PI3K-AKT signaling pathway in myelodysplastic neoplasms

2024-7-25

Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamide

2024-7-24